✦ LIBER ✦

Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies

✍ Scribed by Gene D. Morse; Richard C. Reichman; Margaret A. Fischl; Michael Para; John Leedom; William Powderly; Lisa M. Demeter; Lionel Resnick; Yiannis Bassiakos; Joseph Timpone; Steve Cox; Donald Batts

Book ID: 114145269
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 122 KB
Volume: 45
Category: Article
ISSN: 0166-3542
DOI: 10.1016/s0166-3542(99)00073-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of the pharmacokinetics,

A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection

✍ Rachel W. Humphrey; Kathleen M. Wyvill; Bach-Yen Nguyen; Laura E. Shay; David R. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 143 KB

A phase I/II trial and pharmacokinetic s

A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 187 KB

Phase I Safety and Pharmacokinetic Study

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors

✍ Gerber, D. E.; Stopeck, A. T.; Wong, L.; Rosen, L. S.; Thorpe, P. E.; Shan, J. S 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 346 KB

Erratum to: A phase I/II trial and pharm

Erratum to: A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 86 KB

A phase I/II dose escalating trial evalu

A phase I/II dose escalating trial evaluating safety, tolerability, pharmacokinetics and antiviral activity of clevudine in patients chronically infected with HBV

✍ P. Marcellin; G.K.K. Lau; H. Mommeja-Marin; S. Sacks; D. Sereni; J.P. Bronowicki 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase I dose escalation study of the p

A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI™), in patients with advanced solid tumours

✍ Edwina N. Scott; Anne L. Thomas; L. Rhoda Molife; Samreen Ahmed; Sarah Blagden; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 253 KB